The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.CBRâs market research solutions are focused on being both proactive reactive in identifying, evaluating, and assessing the key strategic R&D and commercial issues within the pharmaceutical industry.
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jan 2019 | Page 99
Achieve an up-to-date understanding of the area, with a comprehensive reference of key products within the gene therapy landscape....
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jan 2019 | Page 108
Global Biosimilars Market provides an in-depth assessment of the current developments and trends in the global biosimilars market. ....
Global Clinical Trials - Current Trends and Recent Advancement
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Jan 2019 | Page 65
Global Clinical Trials - Current Trends and Recent Advancement Global Clinical Trials - Current Trends and Recent Advancement, provides an in-depth assessment of the current trends in the number of clinical....
Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Oct 2017 | Page 72
Rx-to-OTC switching is the process of transferring Rx pharmaceuticals to non-prescription OTC status for the same dosage form, population, and route of administration. OTC drugs are defined as....
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape
By CBR Pharma Insights | Pharmaceuticals and Healthcare | Oct 2017 | Page 57
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape GBI Research’s latest report, Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D....